![Page 1: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/1.jpg)
Filling evidence gaps
Karen Glanz, PhD, MPHEmory University
Glorian Sorensen, PhD, MPHHarvard University
Dana-Farber Cancer Institute
![Page 2: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/2.jpg)
Description
The Cancer Prevention and Control Research Network (CPCRN) is actively engaged in advancing both the science and practice of cancer control through scholarly activities and community engagement. Several of our multicenter activities (completed and in progress) emphasize filling evidence gaps related to cancer prevention and control.
![Page 3: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/3.jpg)
Review Paper of IDM Measures
Mullen PD, Allen JD, Glanz K, Fernandez ME, Bowen DJ, Pruitt SL, Glenn BA, Pignone M. Measures used in studies of informed decision making about cancer screening: A systematic review. [Special Issue] Annals of Behavioral Medicine, 2006;32(3):188-201
Collaboration between 6 centers
FINDINGSMost studies measured screening (or
intention) and knowledge;Fewer measured recommended IDM-related
constructsNone measured all outcomes proposed for
evaluating IDM interventions.
![Page 4: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/4.jpg)
Review RecommendationsNew and in-progress studies:
should emphasize outcomes beyond knowledge – participation in decision-making according
to personal preference satisfaction with the process, and consistency between decisions and values.
need better use of theory to guide conceptualization and operationalization of measures
should give greater attention to reliability and validity (particularly in diverse populations)
need more thorough reporting of sources and operating characteristics of measures
Funders, researchers, and journal editors should place increased emphasis and resources focused on these issues.
![Page 5: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/5.jpg)
Dissemination Forum
“Dissemination Research to Promote Cancer Prevention: Methodological Challenges and Approaches” Fall 2007 in Boston, MA
Hosted by Harvard University, Boston University, Dana-Farber Cancer Institute
Planning Committee included members from all 8 CPCRN centers
Over 100 participants attended from diverse backgrounds
![Page 6: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/6.jpg)
Dissemination Forum (cont.)
AUDIENCE:Community partners, funders, researchers, students and health practitioners from the Boston area CPCRN researchers and community partners from other network centers
OBJECTIVES: Review and compare available frameworks to guide dissemination researchDebate the appropriateness of a range of research designs and methods to the key research questions for dissemination research Identify and discuss challenges to conducting dissemination research across settingsDiscuss implications for funding of dissemination research
![Page 7: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/7.jpg)
Dissemination Forum (cont.)Products in progress:
(1)process for review of dissemination research proposals, instituted following the forum
(2)discussion of a plan for a dissemination research resource center; and
(3)CPCRN sessions (January 2009): Society for Behavioral Medicine
(SBM) meeting the National Cancer Institute (NCI)
Dissemination Research meeting
![Page 8: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/8.jpg)
Multi-center Study“A sustainable approach to increasing
cancer screening in community health centers” (Emmons, PI, Bastani, Co-PI)
Collaboration between Harvard and UCLA
Funded by the National Cancer Institute
Goal: develop, implement, and evaluate a telephone reminder system to increase cancer screening rates
Guided by the Chronic Care Model
![Page 9: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/9.jpg)
Multi-center Study (cont.) “A sustainable approach to increasing cancer
screening in community health centers” (Emmons, PI, Bastani, Co-PI)
Outcomes: decrease no-show rates at scheduled
primary care/screening visits increase screening rates for breast, cervical,
colorectal cancer, and IDM for prostate CA screening.
disseminate Ix to CHCs in Boston and Los Angeles
Evalution of factors influencing adoption and implementation in the dissemination phase
Fills the evidence gap by examining the dissemination of evidence from the Guide
![Page 10: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/10.jpg)
Community Guide Cancer Screening Evidence
Review Update Co-leads: Karen Glanz, PhD, MPH
(Emory)Randy Elder, PhD (CDC)
Updating cancer screening intervention evidence reviews (breast, cervical, colorectal) for the Guide to Community Preventive Services
Evidence review update spans 2004-2008
Coordination Team and Consultation Teams include representatives from all 8 CPCRN network centers
![Page 11: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/11.jpg)
Community Guide Cancer Screening
Evidence Review Update There may be more evidence on invasive
procedures for colorectal cancer screening
3 abstractors are working on preliminary search strategies
Using TrialStats software for abstractions/ review management
Using Base Camp knowledge management system for team planning
THE GUIDE TO
Community
PREVENTIVE
Services
![Page 12: Filling evidence gaps Karen Glanz, PhD, MPH Emory University Glorian Sorensen, PhD, MPH Harvard University Dana-Farber Cancer Institute](https://reader030.vdocuments.mx/reader030/viewer/2022032313/56649e6c5503460f94b6ac0f/html5/thumbnails/12.jpg)
Questions?